A novel role for Bsd2 in the resistance of yeast to adriamycin

Journal of Cellular Physiology

Volumn 202, Issue 1, 2005, Pages 100-104

  Takahashi, Tsutomu ^a   Furuchi, Takemitsu ^a,b   Naganuma, Akira ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACLARUBICIN; BSD 2 PROTEIN; CARRIER PROTEIN; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; EGTAZIC ACID; FLUOROURACIL; PROTEIN; SMF 1 TRANSPORTER; SMF 2 TRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE LIBRARY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; YEAST;

ANTIBIOTICS, ANTINEOPLASTIC; CATION TRANSPORT PROTEINS; CHELATING AGENTS; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, FUNGAL; EGTAZIC ACID; GENE EXPRESSION REGULATION, FUNGAL; INTRACELLULAR FLUID; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 10044269626     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20082     Document Type: Article

References (35)

1. Baudin A, Ozier-Kalogeropoulos O, Denouel A, Lacroute F, Cullin C. 1993. A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae. Nucleic Acids Res 21:3329-3330.
2. Benjamin RS, Wiernik PH, Bachur NR. 1974. Adriamycin chemotherapy - efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer 33:19-27.
3. Booser DJ, Hortobagyi GN. 1994. Anthracycline antibiotics in cancer therapy. Focus on drug resistance. Drugs 47:223-258.
4. Cohen A, Nelson H, Nelson N. 2000. The family of SMF metal ion transporters in yeast cells. J Biol Chem 275:33388-33394.
5. Cole SP, Deeley RG. 1998. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays 20:931-940.
6. Feinstein E, Canaani E, Weiner LM. 1993. Dependence of nucleic acid degradation on in situ free-radical production by adriamycin. Biochemistry 32:13156-13161.
7. Furuchi T, Ishikawa H, Miura N, Ishizuka M, Kajiya K, Kuge S, Naganuma A. 2001. Two nuclear proteins, Cin5 and Ydr259c, confer resistance to cisplatin in Saccharomyces cerevisiae. Mol Pharmacol 59:470-474.
8. Furuchi T, Hwang GW, Naganuma A. 2002. Overexpression of the ubiquitin-conjugating enzyme Cdc34 confers resistance to methylmercury in Saccharomyces cerevisiae. Mol Pharmacol 61:738-741.
9. Furuchi T, Nitta K, Takahashi T, Naganuma A. 2004. Overexpression of Ssl2p confers resistance to adriamycin and actinomycin D in Saccharomyces cerevisiae. Biochem Biophys Res Commun 314:844-848.
10. Gewirtz DA. 1999. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727-741.
11. Gonzalez C, Perdomo G, Tejera P, Brito N, Siverio JM. 1999. One-step, PCR-mediated, gene disruption in the yeast Hansenula polymorpha. Yeast 15:1323-1329.
12. Goossens A, de La Fuente N, Forment J, Serrano R, Portillo F. 2000. Regulation of yeast H(+)-ATPase by protein kinases belonging to a family dedicated to activation of plasma membrane transporters. Mol Cell Biol 20:7654-7661.
13. Hortobagyi GN. 1997. Anthracyclines in the treatment of cancer: An overview. Drugs 54(Suppl 4):1-7.
14. Hwang GW, Furuchi T, Naganuma A. 2002. A ubiquitin-proteasome system is responsible for the protection of yeast and human cells against methylmercury. FASEB J 16:709-711.
15. Ishida S, Lee J, Thiele DJ, Herskowitz I. 2002. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 99:14298-14302.
16. Kolaczkowski M, van der Rest M, Cybularz-Kolaczkowska A, Soumillion JP, Konings WN, Goffeau A. 1996. Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J Biol Chem 271:31543-31548.
17. Lincke CR, van der Bliek AM, Schuurhuis GJ, van der Velde-Koerts T, Smit JJ, Borst P. 1990. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Cancer Res 50:1779-1785.
18. Liu XF, Culotta VC. 1994. The requirement for yeast superoxide dismutase is bypassed through mutations in BSD2: A novel metal homeostasis gene. Mol Cell Biol 14:7037-7045.
19. Liu XF, Culotta VC. 1999. Post-translation control of Nramp metal transport in yeast. Role of metal ions and the BSD2 gene. J Biol Chem 274:4863-4868.
20. Liu XF, Elashvili I, Gralla EB, Valentine JS, Lapinskas P, Culotta VC. 1992. Yeast lacking superoxide dismutase. Isolation of genetic suppressors. J Biol Chem 267:18298-18302.
21. Liu XF, Supek F, Nelson N, Culotta VC. 1997. Negative control of heavy metal uptake by the Saccharomyces cerevisiae BSD2 gene. J Biol Chem 272:11763-11769.
22. Luo W, Chang A. 1997. Novel genes involved in endosomal traffic in yeast revealed by suppression of a targeting-defective plasma membrane ATPase mutant. J Cell Biol 138:731-746.
23. Miura N, Kaneko S, Hosoya S, Furuchi T, Miura K, Kuge S, Naganuma A. 1999. Overexpression of L-glutamine:D-fructose-6-phosphate amidotransferase provides resistance to methylmercury in Saccharomyces cerevisiae. FEBS Lett 458:215-218.
24. Mulet JM, Leube MP, Kron SJ, Rios G, Fink GR, Serrano R. 1999. A novel mechanism of ion homeostasis and salt tolerance in yeast: The Hal4 and Hal5 protein kinases modulate the Trk1-Trk2 potassium transporter. Mol Cell Biol 19:3328-3337.
25. Naganuma A, Miura N, Kaneko S, Mishina T, Hosoya S, Miyairi S, Furuchi T, Kuge S. 2000. GFAT as a target molecule of methylmercury toxicity in Saccharomyces cerevisiae. FASEB J 14:968-972.
26. Portnoy ME, Liu XF, Culotta VC. 2000. Saccharomyces cerevisiae expresses three functionally distinct homologues of the nramp family of metal transporters. Mol Cell Biol 20:7893-7902.
27. Schenk PW, Boersma AW, Brok M, Burger H, Stoter G, Nooter K. 2002. Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype. Mol Pharmacol 61:659-666.
28. Schenk PW, Brok M, Boersma AW, Brandsma JA, Den Dulk H, Burger H, Stoter G, Brouwer J, Nooter K. 2003. Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: A novel component involved in cisplatin- and doxorubicin-provoked cell kill. Mol Pharmacol 64:259-268.
29. Shen J, Hughes C, Chao C, Cai J, Bartels C, Gessner T, Subjeck J. 1987. Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. Proc Natl Acad Sci USA 84: 3278-3282.
30. Singh SV, Nair S, Ahmad H, Awasthi YC, Krishan A. 1989. Glutathione S-transferases and glutathione peroxidases in doxorubicin-resistant murine leukemic P388 cells. Biochem Pharmacol 38:3505-3510.
31. Sinha BK, Mimnaugh EG, Rajagopalan S, Myers CE. 1989. Adriamycin activation and oxygen free radical formation in human breast tumor cells: Protective role of glutathione peroxidase in adriamycin resistance. Cancer Res 49:3844-3848.
32. Ueda K, Clark DP, Chen CJ, Roninson IB, Gottesman MM, Pastan I. 1987. The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem 262:505-508.
33. Withoff S, De Jong S, De Vries EG, Mulder NH. 1996. Human DNA topoisomerase II: Biochemistry and role in chemotherapy resistance. Anticancer Res 16:1867-1880.
34. Wolfger H, Mamnun YM, Kuchler K. 2001. Fungal ABC proteins: Pleiotropic drug resistance, stress response and cellular detoxification. Res Microbiol 152:375-389.
35. Zwelling LA, Hinds M, Chan D, Mayes J, Sie KL, Parker E, Silberman L, Radcliffe A, Beran M, Blick M. 1989. Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. J Biol Chem 264:16411-16420.